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Canalicular microdomains and bile formation
Abstract
This book is the proceedings of the XX International Bile Acid Meeting, Falk Symposium 165 entitled
‘Bile Acid Biology and Therapeutic Actions', held in Amsterdam, The Netherlands, June 13--14, 2008,
and dedicated to both basic and clinical aspects of bile acid research with a focus on the role of bile
acids in hepatobiliary diseases. The latest findings are presented by leading scientists and clinicians in
the field. Since the last International Bile Acid Meeting in Freiburg im Breisgau, Germany, in 2006, bile
acid research has continued to flourish and therapeutic use of bile acids has attained a broader role. New
insights have been gained into the mechanisms responsible for maintenance of bile acid homeostasis,
and effects of bile acids on the cell signalling pathways have been further elucidated. Knowledge about
the genetic basis of bile acid physiology has further increased. Therapy of chronic cholestatic liver
diseases with ursodeoxycholic acid and new aspects of its chemopreventive properties continue to
stimulate basic and clinical research and contribute to the understanding of underlying modes of action
and to optimized treatment schedules.
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Introduction 
Bile formation is a major function of the liver and involves vectorial secretion of lipophilic 
endogenous and exogenous compounds including bile salts, organic anions and lipids (1, 2). 
Due to their high concentrations, the main biliary lipid phosphatidylcholine and bile salts 
form mixed micelles (3). These mixed micelles in turn act as acceptors for poorly water 
soluble compounds. Therefore, the bile fluid is exquisitely suited for the excretion of 
lipophilic endogenous compounds (e.g. cholesterol) and xenobiotics (e.g. drugs). Canalicular 
secretion is critically dependent on the coordinate action of several ATP-binding cassette 
(ABC) transporters: The bile salt export pump (Bsep in rodents, BSEP in humans) 
(Abcb11/ABCB11) mediates bile salt secretion (4), organic anions such as bilirubin 
diglucuronide and glucuronidated or sulfated metabolites of endogenous compounds or of 
xenobiotics are secreted by the multidrug resistance protein 2 (Mrp2/MRP2) (Abcc2/ABCC2) 
(5) and/or by Abcg2/ABCG2 Abcg2/ABCG2 (6), the phosphatidylcholine translocator 
Mdr2/MDR3 (Abcb4/ABCB4) is instrumental for phospholipid secretion (7) and Abcg5 and 
Abcg8/ABCG5 and ABCG8 mediate canalicular cholesterol secretion (8). The biologic role 
of these ATP-dependent transporters, which are capable to generate steep concentration 
gradients across the canalicular membrane, is highlighted by multiple inherited diseases, 
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which have been shown to be caused by mutations in the corresponding human ABC 
transporter genes (9). 
 
Canalicular Lipid Secretion 
Canalicular phospholipid and cholesterol secretion has been studied in detail in both, inherited 
human liver diseases and in animal models. In brief, the following concept has emerged from 
these investigations: The amphipathic bile salts extract after their section into the canaliculus 
phosphatidylycholine from the canalicular membrane. Phosphatidylcholine in turn forms 
mixed micelles with the bile salts in the canaliculus (3). This principle has been worked out in 
animal models demonstrating a) that in the absence of canalicular bile salt secretion 
phospholipid secretion ceases and b) that mice lacking Mdr2, even under high bile salt 
secretion, are not capable of canalicular phospholipid secretion (10). In humans, patients with 
absent bile salt secretion due to a defect in the BSEP gene secrete virtually no phospholipids 
(11), while patients with mutations in the MDR3 gene secrete bile salts but virtually no 
phospholipids into their bile (12). On top of these findings, animals without biliary 
phospholipid secretion display no biliary cholesterol output, unless challenged with a very 
high bile salt output (10). This observation clearly demonstrates that the presence of mixed 
micelles as acceptors for cholesterol is needed in the canaliculus. Mice with disrupted genes 
for Abcg5 or Abcg8 display a marked reduction of biliary cholesterol (13), while patients with 
mutations in the corresponding genes present with hypercholesterolemia (14). It is therefore 
evident from these findings that normal biliary cholesterol secretion critically depends on the 
correct interplay of at least three canalicular ABC transporters. 
Upon in vitro incubation of isolated rat canalicular plasma membrane vesicles with 
conjugated and non-conjugated bile salts, phosphatidylcholine is preferentially released (15, 
16), even though the canalicular phosphatidylcholine content amounts only to about 35 % of 
the total phospholipids. A comparison of the capacity of taurocholate to release 
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phosphatidylcholine from different isolated subcellular fractions and from erythrocytes of 
various species revealed an inverse relationship between the amount of phosphatidylcholine 
released into the supernatant and the sphingolipid content of the membranes (16). 
Interestingly however, the amount of phosphatidylcholine released from isolated canalicular 
plasma membrane vesicles is higher than expected from this relationship. This property of 
canalicular plasma membrane vesicles can be interpreted such that phosphatidylcholine is 
laterally compartmentalized in the canalicular plasma membrane into microdomains and 
hence could be more susceptible to extraction by bile salts. Along these lines, it is interesting 
to note that biophysical in vitro experiments revealed a preferential interaction of cholesterol 
with sphingomyelin in the absence and presence of bile salts (17-22). These data also suggests 
the presence of microdomains in the canalicular plasma membranes. 
 
Microdomains in Plasma Membranes 
Microdomains in plasma membranes are well known, are usually defined by their resistance 
to extraction by nonionic detergents at cold temperature and are also called lipid rafts (23-25). 
These rafts are characterized by their sphingomyelin and cholesterol content, which are 
clustered. Recently, based on detergent extraction at cold temperature, evidence has been 
presented for the presence of microdomains in both the basolateral and in the canalicular 
plasma membrane of hepatocytes (26-28). Besides raft markers such as caveolin-1, 
cholesterol and sphingomyelin, these microdomains were shown to contain the transport 
proteins aquaporin 8 and the sodium-taurocholate cotransporter. Another study presented 
evidence for the presence of two different populations of caveolin-enriched microdomains in 
the hepatocyte plasma membrane, which can be distinguished in their solubility in 1 % Triton 
X-100 (29). 
In a comparative study, which used different detergents for the isolation of detergent resistant 
membranes, it was observed that the different detergents displayed considerable variability in 
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selectively enriching sphingomyelin and cholesterol over other lipids (30). By comparing 
Triton X-100 (critical micellar concentration 0.24 mM, (31)) and Lubrol WX (critical micellar 
concentration 0.02 to 0.06 mM, (31) with several other detergents, the former was identified 
as a more selective and Lubrol WX as a less selective detergent for lipid raft markers in the 
isolation of detergent resistant membranes (30). 
 
Microdomains in the Canalicular Membrane 
To test for the presence of microdomains in the canalicular membrane (32) we therefore 
extracted highly purified canalicular plasma membrane vesicles at cold temperature with 1 % 
Lubrol WX and Triton X-100, respectively, and subjected the extract to flotation in sucrose 
gradients (33). Both detergents yielded floating detergent resistant membranes, which 
quantitatively contained the raft markers alkaline phosphatase and sphingomyelin. In contrast, 
cholesterol was predominantly found in Lubrol WX resistant membranes, but only to a minor 
extent in Triton X-100 resistant membranes. This result was paralleled by the distribution of 
caveolin-1, which was resistant to Lubrol WX extraction (i.e. it associated with the detergent 
resistant membranes), but was almost quantitatively solubilized by Triton X-100. Hence, the 
canalicular plasma membrane contains two different types of microdomains. Next, we 
analyzed canalicular marker enzymes such as aminopeptidase N. Only trace amounts of these 
marker enzymes associated to a similar extent with both types of detergent resistant 
membranes. Analysis of the canalicular ABC transporters Bsep, Mdr2, Abcg5, Mrp2 and 
Mdr1 revealed a differential behavior in the interaction with the two detergents. While they 
were practically completely solubilized with Triton X-100, they were to a large extent 
recovered in Lubrol WX resistant membranes. In conclusion, the results obtained so far 
demonstrate that the canalicular membrane contains two different types of microdomains: 
Lubrol WX microdomains and Triton X-100 microdomains. Lubrol WX microdomains are 
enriched in cholesterol and caveolin-1, while Triton X-100 microdomains are practically 
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devoid of these two established raft markers. Since all the investigated canalicular ABC 
transporters, including the ABC transporters critical for canalicular bile formation, partition 
into Lubrol WX microdomains, these microdomains might be the source of biliary 
cholesterol, which is also present these microdomains. Further experiments are needed to 
define more markers for the two types of microdomains and for the elucidation of the 
physiologic role of Lubrol WX microdomains in bile formation. 
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